Citations & Methodology

Loading...

Academic & Industry References

  1. Epstein D et al. Cost-effectiveness analysis of varicose veins treatments. J Vasc Surg Venous Lymphat Disord 2022;10:504-513.
  2. Beebe-Dimmer JL et al. Epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005;15(3):175-184.
  3. Sharif Nia H et al. Varicose veins among nurses: occupational and demographic characteristics. Int J Nurs Pract 2015;21(3):313-320.
  4. Robertson L, Evans C, Fowkes FGR. Epidemiology of chronic venous disease. Phlebology 2008;23(3):103-111.
  5. Gloviczki P et al. Care of patients with varicose veins: SVS/AVF clinical practice guidelines. J Vasc Surg. 2011;53(5 Suppl):2S-48S.
  6. Almeida JI et al. Radiofrequency ClosureFAST versus laser ablation (RECOVERY study). J Vasc Interv Radiol. 2009;20(6):752-759.
  7. Rasmussen LH et al. RCT comparing endovenous laser ablation, foam sclerotherapy, and surgical stripping. Br J Surg. 2011;98(8):1079-1087.
  8. Intersocietal Accreditation Commission vein standards. https://www.intersocietal.org
  9. NRC Health. Patient preference surveys (200,000+ consumers): convenience (52%) and choice (50%) ranked above insurance coverage (46%).
  10. Davies AH et al. Management of chronic venous disease. Phlebology 2019;34(1S):4-15.
  11. Hamdan A. Management of varicose veins and venous insufficiency. JAMA 2012;308(24):2612-2621.
  12. Thackeray R et al. Social media in health promotion. Health Promotion Practice 2012;13(2):165-172.
  13. Wittens C et al. ESVS clinical practice guidelines for chronic venous disease. Eur J Vasc Endovasc Surg 2015;49(6):678-737.
  14. Varicose Veins Treatment Market — Global Supply & Demand Analysis, Growth Forecasts 2025-2037. https://www.grandviewresearch.com/industry-analysis/varicose-vein-treatment-market
  15. Kim Y et al. Human and health care costs of chronic venous insufficiency. Semin Vasc Surg 2021;34(1):59-64. https://doi.org/10.1053/j.semvascsurg.2021.02.007
  16. Meissner M. Venous Disease: Where are We Going. American College of Phlebology Annual Congress, Orlando, November 2015.
  17. Vasquez MA, Munschauer CE. Venous Clinical Severity Score and QoL tools. Phlebology 2008;23:259-75.
  18. Shepherd AC et al. Disease-specific QoL vs clinical assessments in varicose vein patients. J Vasc Surg 2011;53:374-82.
  19. Launois R et al. CIVIQ quality of life questionnaire for chronic venous insufficiency. Qual Life Res 1996;5:539-54.
  20. Mallick R et al. Treatment patterns and outcomes in patients with varicose veins. Am Health Drug Benefits 2016;9(8):455-465.
  21. American Community Survey 2019-2023. https://www.census.gov/programs-surveys/acs/
  22. U.S. Census Bureau Population Estimates July 2024. https://data.census.gov
  23. Competitor analysis: Google, Yelp, state medical boards, Doximity, LinkedIn, Becton Dickinson proprietary data.
  24. U.S. Census Bureau. Texas population 30.5M; podiatrist and dermatologist ratios consistent with national average (1 per 30,000).
  25. Evans CJ et al. Prevalence of varicose veins and chronic venous insufficiency: Edinburgh Vein Study. J Epidemiol Community Health 1999.
  26. Callam MJ. Epidemiology of varicose veins. Br J Surg 1994.
  27. Mulita F et al. Demographic and clinical characteristics of varicose vein patients. Arch Med Sci Atheroscler Dis 2024;9(1):41-46. doi:10.5114/amsad/183653
  28. Decker SL et al. Patient Travel Patterns and Geographic Market Boundaries. Ann Intern Med 2024;177:1732-1734. https://doi.org/10.7326/ANNALS-24-00857
  29. Burke J et al. Willingness of Older Adults to Travel for Medical Care. JAMA Netw Open 2026;9(2):e2560280. doi:10.1001/jamanetworkopen.2025.60280